Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardio Diagnostics Holdings (CDIO) Depreciation and Depletion (2023 - 2025)

Historic Depreciation and Depletion for Cardio Diagnostics Holdings (CDIO) over the last 3 years, with Q3 2025 value amounting to $40402.0.

  • Cardio Diagnostics Holdings' Depreciation and Depletion rose 990.15% to $40402.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $153279.0, marking a year-over-year increase of 9463.01%. This contributed to the annual value of $113777.0 for FY2024, which is 290203.17% up from last year.
  • According to the latest figures from Q3 2025, Cardio Diagnostics Holdings' Depreciation and Depletion is $40402.0, which was up 990.15% from $37785.0 recorded in Q2 2025.
  • Cardio Diagnostics Holdings' 5-year Depreciation and Depletion high stood at $40402.0 for Q3 2025, and its period low was $1377.0 during Q3 2023.
  • For the 3-year period, Cardio Diagnostics Holdings' Depreciation and Depletion averaged around $25934.4, with its median value being $36762.0 (2024).
  • In the last 5 years, Cardio Diagnostics Holdings' Depreciation and Depletion soared by 256971.68% in 2024 and then surged by 498.17% in 2025.
  • Cardio Diagnostics Holdings' Depreciation and Depletion (Quarter) stood at $2413.0 in 2023, then surged by 1451.43% to $37436.0 in 2024, then rose by 7.92% to $40402.0 in 2025.
  • Its Depreciation and Depletion was $40402.0 in Q3 2025, compared to $37785.0 in Q2 2025 and $37656.0 in Q1 2025.